ArticleActa neuropathologica communications2023

Bruton's tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination.

Kirsten Scarlett Evonuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.